UDV-24867-83252 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-07
Dose 1 — Pfizer-BioNTech
2021-04-28
Dose 2 — Pfizer-BioNTech
2021-04-29
Registered in v-safe
2021-04-29
Survey response — days 1–6 daily, dose 2
MedDRA: Eye pain — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Achy eyes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-05-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-05
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-02
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-11
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-07-28
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-27
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-09
Dose 3 — Pfizer-BioNTech
2022-04-28
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-06-09
Survey response — 6 months, dose 3
MedDRA: Uterine dilation and curettage — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: D&c surgury required (unrelated to any kind of disease)

MedDRA releases: 2024-11 · check-in free text available
2022-06-09
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-06-10
Call 1 — Left Voicemail
2022-12-09
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-07	Pfizer-BioNTech
2	2021-04-28	Pfizer-BioNTech
3	2021-12-09	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-06-09	Unsuccessful

Free text

Release 8 — days 1–6 daily, dose 2

2021-04-29

Systemic reaction (other): Achy eyes

Release 12 — 6 months, dose 3

2022-06-09

Symptoms: D&c surgury required (unrelated to any kind of disease)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Uterine dilation and curettage	·	·	✓
SRO	Eye pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release